These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11338177)

  • 1. Fluoxetine reduces L-DOPA-derived extracellular DA in the 6-OHDA-lesioned rat striatum.
    Yamato H; Kannari K; Shen H; Suda T; Matsunaga M
    Neuroreport; 2001 May; 12(6):1123-6. PubMed ID: 11338177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reuptake of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters.
    Kannari K; Shen H; Arai A; Tomiyama M; Baba M
    Neurosci Lett; 2006 Jul; 402(1-2):62-5. PubMed ID: 16626862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amantadine increases L-DOPA-derived extracellular dopamine in the striatum of 6-hydroxydopamine-lesioned rats.
    Arai A; Kannari K; Shen H; Maeda T; Suda T; Matsunaga M
    Brain Res; 2003 May; 972(1-2):229-34. PubMed ID: 12711097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of selective serotonin reuptake inhibitors via 5-HT1A receptors on L-DOPA-induced rotational behavior in a hemiparkinsonian rat model.
    Inden M; Abe M; Minamino H; Takata K; Yoshimoto K; Tooyama I; Kitamura Y
    J Pharmacol Sci; 2012; 119(1):10-9. PubMed ID: 22510520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats.
    Tanaka H; Kannari K; Maeda T; Tomiyama M; Suda T; Matsunaga M
    Neuroreport; 1999 Feb; 10(3):631-4. PubMed ID: 10208602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of 5-HT(1A) but not 5-HT(1B) receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation.
    Kannari K; Yamato H; Shen H; Tomiyama M; Suda T; Matsunaga M
    J Neurochem; 2001 Mar; 76(5):1346-53. PubMed ID: 11238719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine H(3) receptor ligands modulate L-dopa-evoked behavioral responses and L-dopa derived extracellular dopamine in dopamine-denervated rat striatum.
    Nowak P; Bortel A; Dabrowska J; Biedka I; Slomian G; Roczniak W; Kostrzewa RM; Brus R
    Neurotox Res; 2008; 13(3-4):231-40. PubMed ID: 18522902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: studies in intact and 6-hydroxydopamine-treated rats.
    Miller DW; Abercrombie ED
    J Neurochem; 1999 Apr; 72(4):1516-22. PubMed ID: 10098856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    GoĊ‚embiowska K; Dziubina A
    Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats.
    Conti MM; Ostock CY; Lindenbach D; Goldenberg AA; Kampton E; Dell'isola R; Katzman AC; Bishop C
    Neuropharmacology; 2014 Feb; 77():1-8. PubMed ID: 24067924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation.
    Kannari K; Tanaka H; Maeda T; Tomiyama M; Suda T; Matsunaga M
    J Neurochem; 2000 Jan; 74(1):263-9. PubMed ID: 10617128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alpha(2) adrenoceptor antagonist idazoxan alleviates L-DOPA-induced dyskinesia by reduction of striatal dopamine levels: an in vivo microdialysis study in 6-hydroxydopamine-lesioned rats.
    Buck K; Voehringer P; Ferger B
    J Neurochem; 2010 Jan; 112(2):444-52. PubMed ID: 19895663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia.
    Lindgren HS; Andersson DR; Lagerkvist S; Nissbrandt H; Cenci MA
    J Neurochem; 2010 Mar; 112(6):1465-76. PubMed ID: 20050978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous microdialysis in striatum and substantia nigra suggests that the nigra is a major site of action of L-dihydroxyphenylalanine in the "hemiparkinsonian" rat.
    Orosz D; Bennett JP
    Exp Neurol; 1992 Mar; 115(3):388-93. PubMed ID: 1537396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of benserazide on L-DOPA-derived extracellular dopamine levels and aromatic L-amino acid decarboxylase activity in the striatum of 6-hydroxydopamine-lesioned rats.
    Shen H; Kannari K; Yamato H; Arai A; Matsunaga M
    Tohoku J Exp Med; 2003 Mar; 199(3):149-59. PubMed ID: 12703659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reuptake of L-DOPA-derived extracellular DA in the striatum of a rodent model of Parkinson's disease via norepinephrine transporter.
    Arai A; Tomiyama M; Kannari K; Kimura T; Suzuki C; Watanabe M; Kawarabayashi T; Shen H; Shoji M
    Synapse; 2008 Aug; 62(8):632-5. PubMed ID: 18509855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of adenosine A(2A) receptor antagonists on hydroxyl radical, dopamine, and glutamate in the striatum of rats with altered function of VMAT2.
    GoĊ‚embiowska K; Dziubina A
    Neurotox Res; 2012 Aug; 22(2):150-7. PubMed ID: 22407500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa/benserazide microsphere (LBM) prevents L-dopa induced dyskinesia by inactivation of the DR1/PKA/P-tau pathway in 6-OHDA-lesioned Parkinson's rats.
    Xie CL; Wang WW; Zhang SF; Yuan ML; Che JY; Gan J; Song L; Yuan WE; Liu ZG
    Sci Rep; 2014 Dec; 4():7506. PubMed ID: 25511986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Multimodal Serotonergic Agent Vilazodone Inhibits L-DOPA-Induced Gene Regulation in Striatal Projection Neurons and Associated Dyskinesia in an Animal Model of Parkinson's Disease.
    Altwal F; Moon C; West AR; Steiner H
    Cells; 2020 Oct; 9(10):. PubMed ID: 33050305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.
    Treseder SA; Rose S; Jenner P
    Eur J Neurosci; 2001 Jan; 13(1):162-70. PubMed ID: 11135014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.